Loading…
For people with low intake: maybe modest. The popular claims about glycinate/L-threonate outrun the evidence.
Sleep RCTs on magnesium are small, short, and inconsistent — most benefits seen in deficient subjects.
Our read is Limited Research. The mechanistic story is plausible and the early signals are interesting, but the human outcome data is thin: a largely speculative evidence base (38/100) and only a divided field (42% consensus). At $15/month, taking magnesium for sleep is a bet on preliminary science rather than a settled recommendation.
Pulled the public claims about taking magnesium for sleep from proponents on file (a tracked voice) and weighed them against the more cautious voices (a tracked voice), then cross-checked each against the primary trial and cohort literature and the prevailing clinical guidance. We grade the claim against what the human evidence actually supports, not against how confidently it is stated.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Downside risk on taking magnesium for sleep is low at sensible doses, but low risk is not no risk: individual response varies, and a low-risk intervention is still only worth it if the benefit is real.
A well-designed human outcome trial — the kind that currently does not exist — demonstrating benefit at the doses people actually use.
Mechanistic and trial evidence converge on a real, replicable effect.
The intervention improves the primary outcome at standard doses in healthy adults.
Benefits hold across the populations where it's been tested.
The effect size is large enough to matter clinically, not just statistically.
The intervention improves the primary outcome at standard doses in healthy adults.
Animal-model results don't translate to the human protocol being recommended.
The headline effect shrinks once you account for trial quality.
Animal-model results don't translate to the human protocol being recommended.
Confounding and publication bias inflate the apparent benefit.
Confounding and publication bias inflate the apparent benefit.